S.A. Mitchell

2.4k total citations · 1 hit paper
41 papers, 1.7k citations indexed

About

S.A. Mitchell is a scholar working on Hepatology, Epidemiology and Hematology. According to data from OpenAlex, S.A. Mitchell has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 7 papers in Epidemiology and 7 papers in Hematology. Recurrent topics in S.A. Mitchell's work include Liver Diseases and Immunity (10 papers), Liver Disease Diagnosis and Treatment (6 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). S.A. Mitchell is often cited by papers focused on Liver Diseases and Immunity (10 papers), Liver Disease Diagnosis and Treatment (6 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). S.A. Mitchell collaborates with scholars based in United Kingdom, United States and Germany. S.A. Mitchell's co-authors include Pollyanna Hudson, Josep M. Badía, Nicola Petrosillo, Cynthia T. Crosby, Anna Casey, M.R. Davidson, E. Schrumpf, Kirsten Muri Boberg, R Chapman and David J. Brenner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

S.A. Mitchell

39 papers receiving 1.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries

2017 597 citations Pollyanna Hudson, S.A. Mitchell et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
S.A. Mitchell	868	382	360	322	308	41	1.7k
U. Martinowitz	1.2k 1.4×	151 0.4×	356 1.0×	533 1.7×	313 1.0×	187	6.3k
Bruce E. Jarrell	2.0k 2.3×	452 1.2×	888 2.5×	202 0.6×	376 1.2×	126	4.1k
Madhukar S. Patel	1.6k 1.8×	438 1.1×	1.8k 4.9×	1.1k 3.4×	270 0.9×	129	3.4k
Yvonne Henskens	361 0.4×	64 0.2×	326 0.9×	481 1.5×	180 0.6×	123	2.6k
Dierk Vorwerk	1.9k 2.2×	88 0.2×	2.1k 5.8×	360 1.1×	420 1.4×	167	3.6k
Rajiv K. Pruthi	636 0.7×	45 0.1×	286 0.8×	416 1.3×	119 0.4×	179	3.2k
Gert Printzen	834 1.0×	28 0.1×	243 0.7×	520 1.6×	515 1.7×	30	1.7k
Leo P. Lawler	1.2k 1.4×	116 0.3×	670 1.9×	148 0.5×	299 1.0×	77	2.1k
Harry H. LeVeen	795 0.9×	365 1.0×	446 1.2×	92 0.3×	248 0.8×	82	1.9k
Siegfried Thurnher	1.7k 1.9×	239 0.6×	2.5k 6.9×	712 2.2×	346 1.1×	81	3.4k

Countries citing papers authored by S.A. Mitchell

Since Specialization

Citations

This map shows the geographic impact of S.A. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.A. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.A. Mitchell more than expected).

Fields of papers citing papers by S.A. Mitchell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.A. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.A. Mitchell. The network helps show where S.A. Mitchell may publish in the future.

Co-authorship network of co-authors of S.A. Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of S.A. Mitchell. A scholar is included among the top collaborators of S.A. Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.A. Mitchell. S.A. Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sharif, Asma, Móiad Alazzam, Catherine Howell, et al.. (2025). Intraoperative Ultrasound as a Decision-Making Tool in Modern Gynecologic Oncology. Journal of Personalized Medicine. 15(7). 296–296. 1 indexed citations

Fitzgibbon, Maria, S.A. Mitchell, Catherine Mitchell, et al.. (2025). Patient experience and burden of haemolytic disease of the foetus and newborn: a systematic review. BMC Pregnancy and Childbirth. 25(1). 114–114. 2 indexed citations

Mitchell, S.A., et al.. (2024). Accuracy of ultrasound, magnetic resonance imaging and intraoperative frozen section in the diagnosis of ovarian tumours: data from a London tertiary centre. SHILAP Revista de lepidopterología. 2(1). 50–50. 1 indexed citations

Mitchell, Catherine, et al.. (2019). PSY32 DELAY IN DIAGNOSIS OF PRIMARY LYMPHOEDEMA AND ITS IMPACT ON QUALITY OF LIFE: A SYSTEMATIC REVIEW. Value in Health. 22. S907–S907.

Cohen, Alexander T., M. Hamilton, Alex Bird, et al.. (2016). Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. PLoS ONE. 11(8). e0160064–e0160064. 47 indexed citations

Cohen, Alexander T., M. Hamilton, S.A. Mitchell, et al.. (2015). Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. PLoS ONE. 10(12). e0144856–e0144856. 134 indexed citations

Trautmann, Matthias, Javier Sabater, James W. Shaw, et al.. (2014). Relevance of clinical trials to inform HTA: Disparity between hta evidence requirements and published rcts in type 2 diabtetes mellitus. Value in Health. 17(3). A263–A263. 1 indexed citations

Patel, Amrutlal K., et al.. (2014). The Selection of Appropriate Health State Utility Values (Hsuvs) for Health Technology Assessment (Hta): Lessons To Be Learnt. Value in Health. 17(7). A573–A573. 1 indexed citations

Batson, Sarah, S.A. Mitchell, & Denise King. (2014). The Use and Acceptance of Novel Statistical Analyses To Support Technology Submissions To Hta Authorities. Value in Health. 17(7). A576–A577. 1 indexed citations

10.

King, Denise, et al.. (2014). Systematic Review of Societal Cost of Illness Evidence in Patients With Ankylosing Spondylitis. Value in Health. 17(7). A378–A378. 1 indexed citations

11.

Phatak, Hemant, et al.. (2013). Epidemiology and mortality of venous thromboembolism across patient populations: A systematic literature review. Value in Health. 16(3). A272–A272. 6 indexed citations

12.

Phatak, Hemant, et al.. (2013). Quality of Life in Patients with Venous Thromboemoblism: A Systematic Literature Review. Value in Health. 16(7). A533–A533. 2 indexed citations

13.

Grković, Lana, Kristin Baird, Seth M. Steinberg, et al.. (2011). Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity. Leukemia. 26(4). 633–643. 43 indexed citations

14.

Lockhart, Ian, Michelle Orme, & S.A. Mitchell. (2011). The Efficacy of Licensed-Indication Use of Donepezil and Memantine Monotherapies for Treating Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: Systematic Review and Meta-Analysis. Dementia and Geriatric Cognitive Disorders Extra. 1(1). 212–227. 25 indexed citations

15.

Mitchell, S.A., Neil Emmison, & Alexander G. Shard. (2002). Spatial control of cell attachment using plasma micropatterned polymers. Surface and Interface Analysis. 33(9). 742–747. 30 indexed citations

16.

Mitchell, S.A., Jane I. Grove, Anne Spurkland, et al.. (2001). Association of the tumour necrosis factor α −308 but not the interleukin 10 −627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut. 49(2). 288–294. 79 indexed citations

17.

Mitchell, S.A., et al.. (1998). Role of interleukin-10 in the pathogenesis of primary sclerosing cholangitis and primary biliary cirrhosis?. Gut. 43. 153–153. 1 indexed citations

18.

Mitchell, S.A., et al.. (1997). Decreased interleukin-10 mRNA expression in primary sclerosing cholangitis and primary biliary cirrhosis: A role for IL10 in the pathogenesis?. Hepatology. 26. 1253–1253. 2 indexed citations

19.

Mitchell, S.A., et al.. (1997). Cytokine profiles in primary sclerosing cholangitis (PSC) and autoimmune liver diseases: Comparing expression in the periphery and the liver.. Hepatology. 26. 400–400. 1 indexed citations

20.

Mitchell, S.A., et al.. (1997). High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.. Gastroenterology. 112. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact